🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔈We Are Hiring!🔈 My lab at Genitourinary Cancer Research Team @CityofHope has a post-doc position opening up in 2025. Candidates must have prior research experience, completed their MD/DO, and a passion for clinical & translational GU oncology research. DM me if interested!

🚨 New Paper Alert! 🚨 Excited to share our latest review on 1st and 2nd -line treatments in mRCC in European Urology , co-authored by @reneesaliby, Eddy Saad, Maxine Sun, and @drchoueiri among many of the leading experts in the fields. Check it out! authors.elsevier.com/c/1k2yF14kplyz… (0/10)

The two faces of FOXA1 muts in PCa. Congrats to Justin Hwang for this revised classification of FOXA1 alts in PCa. Different FOXA1 classes have different biologic behaviors, clinical outcomes & racial clustering, esp. Class 1B and 2. @UMNcancer Scott Dehm aacrjournals.org/clincancerres/…

1/ Results from #LITESPARK-003 cohort 1 (1st Line) are out The Lancet Oncology! This phase II trial examined HIF2 inh Belzutifan (BEL) + VEGF TKI Cabozantinib (CABO) in pts w/ 1L advanced ccRCC Check it out: sciencedirect.com/science/articl…

Mindfulness via smartphone AmDTx Mentored by Sumanta K. Pal, MD, FASCO & Dr. Linda E. Carlson 🇨🇦 🇨🇦, this multinational study demonstrates that a mindfulness app improves emotional symptoms, fatigue, & QOL in patients w mRCC on IO ‼️Accessible, feasible, & impactful! academic.oup.com/oncolo/article…

We are so honored to have esteemed international guests like Andrea Necchi Michiel van der Heijden Tom Powles Laurence Albiges Cris Daniel Heng KSridhar join us for #AUC3. And agree w Shilpa Gupta - learned so much from Andrea’s brilliant talk on variant histo in #NMIBC. Lots to think

Congrats to 3 young investigators👇from GU Cancer Research Program @HuntsmanCancer for ASCO #GU25 Conquer Cancer, the ASCO Foundation Merit Award! Zeynep Irem Ozay, MD Nicolas Sayegh, MD #DiyaGarg Names of all investigators who received the award👉 bit.ly/40HI1ma Abstract search👉 bit.ly/3EfRs4O UroToday.com Prostate Cancer Foundation OncoAlert

A meeting for my #SoCal colleagues. No lengthy travel required. Join us in #NewportBeach to discuss the current status of clinical trials in our area for #kidneycancer, #bladdercancer and #prostatecancer. Keynote from Andrea Necchi, our “external reviewer”, who will be offering

Southern California fellows, residents, medical students, and early-career researchers in #GU cancers: Showcase your latest research in prostate, bladder, kidney, and other #GUcancers at the 2nd Annual Southern California Genitourinary Cancer Research Forum SCGCRC on

We are getting awfully close to a full house for #SoCalGU25! Come join us at the Balboa Bay Club ⚓️ on Friday, Feb 28, for full day of #clinicaltrial discussions on #GU cancers. We look forward to hosting speakers from UC Irvine, UCLA Health, USC Urology, City of Hope | Orange County,

🚀 First-Time at ASCO #GU25? Here’s What You Need to Know! 🎯 📅 Plan ahead! This is more intimate than ASCO, so take advantage of smaller sessions to connect with experts 💬 Engage with presenters! 📲 Don’t just attend, participate! Share insights on #GU25, join discussions,

So long #GU25! See you next year ✌🏼

I am so proud! Sabrina Kahla Salgia has one of the kindest hearts I have ever met among any of my students. It was an honor to work with her & look forward to seeing her continue to rise with my dear friends at Harbor-UCLA Medical Center! Alex Chehrazi-Raffle, MD Tanya Dorff Marcel van den Brink Abhishek Tripathi Alexis LeVee, MD

Federal #kidneycancer research funding drops from $50 million to ZERO after 57% cut to CDMRP. All but 12 of the 35 disease research programs saw funding eliminated for 2025, including the Kidney Cancer Research Program. More about the impact on our blog. bit.ly/4hoXnCq

🧵 1/7 Newly published Journal of Clinical Oncology #OncologyAdvances! Our study explores how insurance status affects survival outcomes for patients with metastatic renal cell carcinoma (mRCC) receiving first-line systemic therapy. Read here: doi.org/10.1200/OA.24.…

Best talk I have been to all year was right here at City of Hope at our GU retreat (organized by Alex Chehrazi-Raffle, MD). Yun Rose Li City of Hope - Department of Radiation Oncology just delivered a tour de force highlighting her work in #prostatecancer w Tanya Dorff et al focused on fasting interventions & other metabolic

🎖️Trainees in oncology and across all fields of medicine! Do not miss this manuscript on how to effectively respond to reviewer comments! Thanks Andrew Vickers Rod Dunn Christian Gratzke Morgan Roupret Alberto Briganti et al. European Urology Eur Urol Focus European Urology Oncology 🙏 OncoAlert

Had a chance to celebrate Alex Chehrazi-Raffle, MD's new paper in ESMO Open (co-first auth: Miguel Zugman) over lunch today at SWOG Cancer Research Network! This multicenter collaboration exploring HDCT regimens (CE/TICE) required years of effort in which he pooled data across City of Hope, UCSF Helen Diller Family Comprehensive Cancer Ctr, USC Norris Comprehensive Cancer Center &

🚨Check out our multicenter study that compared the most commonly used high-dose chemo regimens for refractory #GCT. HUGE thanks to our collaborators at UCSF Helen Diller Family Comprehensive Cancer Ctr UC Davis Health UCLA Jonsson Comprehensive Cancer Center, and Miguel Zugman Sumanta K. Pal, MD, FASCO Tanya Dorff Matthew Mei for their leadership & support! 🙏🏼

1/ Huge thanks to all collaborators, but especially to Alex Chehrazi-Raffle, MD , great friend and mentor, for the opportunity to contribute to this multicenter study on HDCT in refractory/recurrent #GCT!